The latest study on Human Immunodeficiency Virus (HIV)-1 Therapeutics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Human Immunodeficiency Virus (HIV)-1 Therapeutics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
AbbVie, Inc.(U.S.)
Merck & Co., Inc. (U.S.)
Bristol-Myers Squibb Company (U.S.)
Boehringer Ingelheim GmbH (Germany)
Genentech, Inc. (U.S.)
Cipla, Inc. (India)
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Type Segment:
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Application Segment:
Hospitals
Clinics
Labs
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Regions (Countries):
The Human Immunodeficiency Virus (HIV)-1 Therapeutics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Human Immunodeficiency Virus (HIV)-1 Therapeutics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Human Immunodeficiency Virus (HIV)-1 Therapeutics Market:
Human Immunodeficiency Virus (HIV)-1 Therapeutics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Human Immunodeficiency Virus (HIV)-1 Therapeutics Market status and future forecast.
To present the key Human Immunodeficiency Virus (HIV)-1 Therapeutics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type (2016-2027)
1.4.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.4.4 Entry and Fusion Inhibitors
1.4.5 Protease Inhibitors (PIs)
1.4.6 Integrase Inhibitors
1.4.7 Coreceptor Antagonists
1.5 Market by Application
1.5.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Labs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size
2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Growth Trends by Regions
2.2.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (2016-2027)
2.2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Manufacturers
3.1.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Manufacturers (2020)
3.1.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players Head office and Area Served
3.3 Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product/Solution/Service
3.4 Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020)
4.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020)
5 United States
5.1 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
5.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in United States
5.3 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
5.4 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
6 Europe
6.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
6.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Europe
6.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
6.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
7 China
7.1 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
7.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in China
7.3 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
7.4 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
8 Japan
8.1 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
8.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Japan
8.3 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
8.4 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
9.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
9.4 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
10 India
10.1 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
10.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in India
10.3 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
10.4 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2016-2020)
11.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Central & South America
11.3 Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
11.4 Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
12 International Players Profiles
12.1 AbbVie, Inc.(U.S.)
12.1.1 AbbVie, Inc.(U.S.) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.1.4 AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
12.1.5 AbbVie, Inc.(U.S.) Recent Development
12.2 Merck & Co., Inc. (U.S.)
12.2.1 Merck & Co., Inc. (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.2.4 Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
12.2.5 Merck & Co., Inc. (U.S.) Recent Development
12.3 Bristol-Myers Squibb Company (U.S.)
12.3.1 Bristol-Myers Squibb Company (U.S.) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
12.3.5 Bristol-Myers Squibb Company (U.S.) Recent Development
12.4 Boehringer Ingelheim GmbH (Germany)
12.4.1 Boehringer Ingelheim GmbH (Germany) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.4.4 Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
12.4.5 Boehringer Ingelheim GmbH (Germany) Recent Development
12.5 Genentech, Inc. (U.S.)
12.5.1 Genentech, Inc. (U.S.) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.5.4 Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
12.5.5 Genentech, Inc. (U.S.) Recent Development
12.6 Cipla, Inc. (India)
12.6.1 Cipla, Inc. (India) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.6.4 Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
12.6.5 Cipla, Inc. (India) Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Market Segments
Table Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Covered
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type 2016-2027
Figure Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Figures
Table Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Figure Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Figures
Table Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure Entry and Fusion Inhibitors Figures
Table Key Players of Entry and Fusion Inhibitors
Figure Protease Inhibitors (PIs) Figures
Table Key Players of Protease Inhibitors (PIs)
Figure Integrase Inhibitors Figures
Table Key Players of Integrase Inhibitors
Figure Coreceptor Antagonists Figures
Table Key Players of Coreceptor Antagonists
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Labs Case Studies
Figure Human Immunodeficiency Virus (HIV)-1 Therapeutics Report Years Considered
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2027 (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions 2016-2027 (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions 2016-2020 (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions 2016-2020
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions 2016-2020
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions 2020
Table Market Top Trends
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Manufacturers (2020) (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Manufacturers (2020)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Manufacturers in 2020
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product/Solution/Service
Table Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Type (2016-2020)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2016-2020)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Application (2016-2020)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2016-2020)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Application in 2020
Figure United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table United States Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table United States Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Figure Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table Europe Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table Europe Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Figure China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table China Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table China Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Figure Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table Japan Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table Japan Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Figure Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Figure India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table India Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table India Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Figure Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2020) (Million US$)
Table Central & South America Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2020)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2016-2020)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2016-2020)
Table AbbVie, Inc.(U.S.) Company Details
Table AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020) (Million US$)
Figure AbbVie, Inc.(U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
Table AbbVie, Inc.(U.S.) Recent Development
Table Merck & Co., Inc. (U.S.) Company Details
Table Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)(Million US$)
Figure Merck & Co., Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
Table Merck & Co., Inc. (U.S.) Recent Development
Table Bristol-Myers Squibb Company (U.S.) Company Details
Table Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)(Million US$)
Figure Bristol-Myers Squibb Company (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
Table Bristol-Myers Squibb Company (U.S.) Recent Development
Table Boehringer Ingelheim GmbH (Germany) Company Details
Table Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)(Million US$)
Figure Boehringer Ingelheim GmbH (Germany) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
Table Boehringer Ingelheim GmbH (Germany) Recent Development
Table Genentech, Inc. (U.S.) Company Details
Table Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)(Million US$)
Figure Genentech, Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
Table Genentech, Inc. (U.S.) Recent Development
Table Cipla, Inc. (India) Company Details
Table Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)(Million US$)
Figure Cipla, Inc. (India) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2020)
Table Cipla, Inc. (India) Recent Development
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Regions (2021-2027)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Regions in 2027
Figure United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2021-2027)(Million USD)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Product (2021-2027) (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Product (2021-2027)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Product in 2027
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2021-2027) (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2021-2027)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources